project id: TCGA-GBM; case submitter id: TCGA-19-A6J4; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.5; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.34; rna integrity number: 8.4; age at index: 68; days to birth: -25058; days to death: 121; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Dead; year of birth: 1945; year of death: 2013; age at diagnosis: 25058; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C71.9; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Brain, NOS; synchronous malignancy: No; tissue or organ of origin: Brain, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 77; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-19-A6J4-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 45.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 15.0; percent tumor cells: 30.0; percent tumor nuclei: 70.0;